Frounfelker, Rochelle
,
Gilman, Stephen E.
Betancourt, Theresa S.
Aguilar-Gaxiola, Sergio
Alonso, Jordi
Bromet, Evelyn J.
Bruffaerts, Ronny
de Girolamo, Giovanni
Gluzman, Semyon
Gureje, Oye
Karam, Elie G.
Lee, Sing
Lépine, Jean-Pierre
Ono, Yutaka
Pennell, Beth-Ellen
Popovici, Daniela G.
ten Have, Margreet
Kessler, Ronald C.
Funding for this research was provided by:
National Institute of Mental Health (R01 MH070884, R01 MH093612-01)
John D. and Catherine T. MacArthur Foundation
Pfizer Foundation
U.S. Public Health Service (R13-MH066849)
Fogarty International Center (FIRCA R03-TW006481)
Pan American Health Organization
Eli Lilly and Company
Ortho-McNeil Pharmaceutical, Inc.
GlaxoSmithKline
Bristol-Myers Squibb
European Commission (QLG5-1999-01042)
Piedmont Region
Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023)
National School of Public Health and Health Services Management
Ministry of Public Health
Eli Lilly Romania SRL
Intramural Research Program, NICHD
Article History
Received: 9 May 2017
Accepted: 22 October 2017
First Online: 8 November 2017
Compliance with ethical standards
:
: In the past 3 years, Dr. Kessler received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services Inc. Lake Nona Life Project. Kessler is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research.